Breast cancer patterns in Iraq
Clinicopathological analysis of PMBC
Biomarkers in Breast Cancer
IL-40 as a biomarker in Iraqi BC
TNBC genomic profiling
Immunopathological mechanisms in TNBC
BC Trends & 2030 Projections
Real-world outcomes of T-DM1 biosimilar
Inflammatory indexes and NAC in BC
CDK4 in luminal breast tumors
TNBC with RAD51D gene mutation
CD163 and Metastasis
